If your child struggles with their vision, focus, or eye control, they might also have low self-esteem due to the way their condition is being perceived by others. Your child’s doctor or ...

Age-related macular degeneration (AMD) gradually affects central vision in one or both eyes while leaving peripheral vision (on the sides) intact. This peripheral vision – encompassing everything you ...

The biotechnology company disclosed interim human trial data for its RV-001 optogenetic treatment aiming to restore sight in ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

New Vision Therapy, PLLC is made up of a variety of therapists using numerous therapeutic approaches. We work with adolescents and adults in individual, group, and family therapeutic sessions. If you ...

This ocular condition happens as the result of a slight eye misalignment, which can cause symptoms such as dizziness and blurry vision. Treatment includes specialty lenses and vision therapy. Share on ...

The PRIME status for RTx-015 was granted based on preliminary Phase I/II safety and efficacy clinical data.

Nanoscope Therapeutics is back with more data assessing its gene therapy that uses light-sensitive molecules to treat retinal disease. With data demonstrating vision improvement in hand, the biotech ...

Please provide your email address to receive an email when new articles are posted on . Optometrists sometimes suggest vision therapy to improve visual skills, addressing perceptual vision and myopia.

Binocular vision dysfunction (BVD) is a condition that affects vision. It can cause a range of symptoms, such as double vision, light sensitivity, pain with eye movement, and more. BVD makes it ...

If a teacher says that a child is struggling to pay attention in class, the quick conclusion might be to get them tested for ADHD. A Bethesda-based neuro-optometrist says it might be something else: ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...